In the future, H19 may also prove useful as a novel diagnostic biomarker for ovarian reserve and premature ovarian insufficiency, and has the potential to improve our diagnosis of DOR especially in situations where current ovarian reserve testing has proven inadequate. Here, H19 is linked to premature menopause.